The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear Cardiology (ASNC) submitted a letter to BlueCross BlueShield (BCBS) of Tennessee urging an expansion of cardiac PET coverage.

Full Text

GE Healthcare and Lantheus Medical Imaging have launched a second phase III clinical trial for Lantheus' flurpiridaz F-18 investigational PET radiopharmaceutical.

Full Text

Florbetapir-PET scans show that midlife adults with two or more vascular risk factors are significantly more likely to have greater levels of amyloid deposits in their brains later in life than peers with no such risk factors, according to a study published April 11 in the Journal of the American Medical... Read More

Heart disease is a danger like no other, meaning proper diagnosis is of paramount importance. PET scans have been, and continue to be, the best way to get such a diagnosis.

Full Text

POSITRON ANNOUNCES SALE OF ATTRIUS PET SCANNER

Niagara Falls, NY –September 5, 2018 – Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, is pleased to announce the sale of its Attrius PET scanner to a prominent cardiology practice in the US as they expand their services to... Read More

POSITRON APPOINTS NEW MANAGEMENT

ADEL ABDULLAH PRESIDENT & AARON HARGRAVE VICE PRESIDENT

Niagara Falls, NY –August 2, 2018– Positron Corporation (OTC:POSC)(the “Company”), a nuclear medicine healthcare company, announces the appointment of Adel Abdullah  as its President. Mr. Abdullah will also serve as a... Read More